ОРГАНИЗАЦИЯ БИОБАНКА ДНК И ЕГО РОЛЬ В НАУЧНЫХ ИССЛЕДОВАНИЯХ
Введение. Современные молекулярно-генетические исследования полиморфизмов генов предрасположенности к различным мультифакторным заболеваниям требуют анализа большого массива клинической информации и генетических данных, которые характеризуют индивидуальные особенности каждого человека. С этой целью создаются информационные базы данных биологических материалов, которые играют центральную роль в объединении большого объема биологических образцов и информации о них.
Цель. Показать значение организации биобанка ДНК и его роль в научных исследованиях.
Результаты. В рамках выполнения проекта «Генетические исследования преэклампсии в популяциях Центральной Азии и Европы», Inter regGen 7 рамочной программы Европейской Комиссии по Грантовому соглашению №282540 на базе Научного центра акушерства, гинекологии и перинатологии МЗ РК (НЦАГиП) проведена организация биобанка ДНК. ДНК выделяли солевым методом из периферической крови рекрутируемых по изученным нозологиям. Молекулярно-генетические исследования проводили TaqMan методом единой сайт специфичной амплификации и генотипирования в реальном времени (Real-Time PCR) с использованием тест-систем («Тест Ген», Россия) для молекулярно-генетических исследований.
Выводы. Коллекция ДНК биобанка используется для проведения научных исследований мультифакторных заболеваний с невыясненным патогенезом, выявления биомаркеров, создания диагностических тестов в рамках научно-технических программ.
Галина М. Березина 1, http://orcid.org/0000-0002-5442-4461
Динара Д. Мирзахметова 1, http://orcid.org/0000-0002-6329-5999
Гульнара C. Святова 1, http://orcid.org/0000-0001-5092-3143,
Айгуль Т. Терликбаева 1, http://orcid.org/0000-0002-1777-805Х
Александра В. Муртазалиева 1, http://orcid.org/0000-0001-9156-5944
Акционерное общество «Научный центр акушерства, гинекологии и перинатологии»,
г. Алматы, Республика Казахстан
1. Брагина Е.Ю., Буйкин С.В., Пузырев В.П. Биологические банки: проблемы и перспективы их использования в исследованиях генетических аспектов комплексных заболеваний человека // Медицинская генетика. 2009. № 3. С. 20-27.
2. Брызгалина Е.В., Аласания К.Ю., Садовничий В.А., Миронов В.В., Гавриленко С.М., Вархотов Т.А., Шкомова Е.М., Набиулина Е.А. Социально-гуманитарная экспертиза функционирования национальных депозитариев биоматериалов // Вопросы философии. 2016. №2. С. 18–21 http://vphil.ru/index.php?option=com_content&task=view&id=1346&Itemid=5
3. Буйкин С.В., Брагина Е.Ю., Конева Л.А., Пузырев В.П. Базы данных коллекций биологического материала: организация сопроводительной информации // Бюллетень сибирской медицины. 2012. № 1(26). С. 111-121.
4. Вархотов Т.А. и др. Задачи социально-гуманитарного сопровождения создания национального банка-депозитария биоматериалов // Вопросы философии. 2016. № 3. С. 124–138.
5. Еропкин М.Ю. Биобанки и их роль в системах биобезопасности, здравоохранения, биотехнологии, экологии и «экономике знаний» ФГБУ «НИИ гриппа» Минздрава России. 2015. P 1-25. www.influenza.spb.ru
6. Игнасимуту С. Основы биоинформатики. М.; Ижевск: НИЦ «Регулярная и хаотическая динамика». Институт компьютерных исследований, 2007. 320 с.
7. Коншина О.С., Еропкин М.Ю., Никоноров И.Ю., Позднякова М.Г. Роль биобанков в изучении популяционного иммунитета // Журнал инфектологии. 2018. том 10, № 2 С.39-47. doi: 10.22625/2072-6732-
8. Малеина М.Н. Правовой статус биобанка (банка биологических материалов человека) // Право. Журнал Высшей школы экономики. 2020. № 1. С. 98–117. doi: 10.17323/2072-8166.2020.1.98.117
9. Мирзахметова Д.Д. Святова Г.С., Березина Г.М., Муртазалиева А.В. Клинико-диагностическая значимость генов предрасположенности к преэклампсии в казахской популяции // Акушерство и гинекология. 2020. №3 С.58-63. https://dx.doi.org/10.18565/aig.2020.3.58-63
10. Михайлова А.А., Насыхова Ю.А., Муравьев А.И., Ефименко А.Ю., Глотов А.С. На пути к созданию общего глоссария биобанков Российской Федерации // Кардиоваскулярная терапия и профилактика. 2020. 19(6) С.134-148 doi:10.15829/1728-8800-2020-2710
11. Мохов А.А. Биобанкинг - новое направление экономической деятельности // Вестник МГЮА. 2018. № 3. С. 33–40.
12. Об утверждении правил создания и деятельности биобанков. Приказ и.о. Министра здравоохранения Республики Казахстан от 24 декабря 2020 года № ҚР ДСМ-328/2020
13. Пржиленский В.М., Вергун А.А. Правовое регулирование деятельности геномных банков в контексте социального, культурного и нормативного многообразия // Актуальные проблемы российского права. 2019. № 3. С. 30–37.
14. Резник О.Н., Кузьмин Д.О., Скворцов А.Е., Резник А.О. Биобанки – неоценимый ресурс трансплантации. История, современное состояние, перспективы. // Вестник трансплантологии и искусственных органов. 2016. том XVIII № 4 C.123-132. doi: 10.15825/1995-1191
15. Румянцев П.О., Мудунов А.М. Биобанкинг в онкологии и радиологии // Эндокринная хирургия. 2017. Т. 11. №4. С. 170–177. doi: 10.14341/serg9555
16. Святова Г.С., Березина Г.М., Мамедалиева Н.М., Аимбетова А.Р., Муртазалиева А.В. Молекулярно-генетическая диагностика и алгоритм ведения беременных с идиопатической формой привычного невынашивания // Методические рекомендации, 2019. 28с. №206 РГП на ПХВ «РЦРЗ», ISBN 978-601-305-371-4
17. Святова Г.С., Березина Г.М., Миербеков Е.М., Муртазалиева А.В. Частоты аллелей и генотипов, ассоциированных с эффективностью антикоагулянтной терапии, в казахской популяции // «Медицинская генетика», 2018. №9. С.37-44. https://doi.org/10.25557/2073-7998.2018.09.37-44
18. Святова Г.С., Березина Г.М., Муртазалиева А.В. Ассоциация полиморфизма гена хромосомной сегрегации SYCP3 с идиопатической формой привычного невынашивания беременности в казахской популяции. // Акушерство и гинекология, 2019. №12 С.105-110. https://dx.doi.org/10.18565/aig.2019.12.105-110
19. Святова Г.С., Березина Г.М., Салимбаева Д.Н., Кирикбаева М.С., Муртазалиева А.В.,Садуакасова К.З. Генетические аспекты идиопатической формы привычного невынашивания беременности. (Обзор литературы) // Наука и здравоохранение, 2019. №4 (Т.21). С.37-49. ISSN2410 – 4280
20. Смирнова Ю. «Банковское дело» как путь к персонифицированной медицине // Наука и жизнь. 2013 №1 https://www.nkj.ru/archive/articles/21579/
21. Центр коллективного пользования «Биобанк», ФГБУ «НМИЦ им. В.А.Алмазова» Минздрава России. http://www.almazovcentre.ru/?page_id=69701
22. Allocca C.M., Bledsoe M.J., Furuta K., Ramirez N.C. ISO/TC276/WG2 Biobanks and Bioresources: Draft International Standard Is Now Available for Comment. // Biopreserv. Biobank. 2017. Vol. 15(4). P.399–401. doi: 10.1089/bio.2017.29025.cma
23. Asslaber M., Zatloukal K. Biobanks: transnational, European and global networks // Brief Funct Genomic Proteomic. 2007. Vol. 6(3). P.193-201. doi: 10.1093/bfgp/elm023. Epub 2007 Oct 4.
24. Barbour V. UK Biobank: a project in search of a protocol? // Lancet (London, England). 2003. 361(9370). P.1734-1738. DOI:10.1016/s0140-6736(03)13377-6
25. Berezina G., Svyatova G., Aimbetova A. “Genes of predisposition to misseb abortion in kazakh population” // Abstract book / International scientific conference «Personalized medicine & Global Health». 2017 г. P 46.
26. Best Practices for Repositories Collection, Storage, Retrieval, and Distribution of Biological Materials for Research International Society for Biological and Environmental Repositories // Biopreserv. Biobank. 2012. 10. 79–161.
27. Betsou F., Bulla A., Cho S.Y., Clements J., Chuaqui, R. et.al. Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group // Biopreserv. Biobank. 2016. 14(5). P.398–409. doi: 10.1089/bio.2016.0018
28. Bingham S., Riboli E. Diet and cancer — the European prospective investigation into cancer and nutrition // Nat. Rev. Cancer. 2004. V. 4(3). P. 206—215. doi: 10.1038/nrc1298
29. Bourgeois F., Avillach P., Kong S., Heinz M., Tran T. Development of the Precision Link Biobank at Boston Children’s Hospital: Challenges and Opportunities // J. Pers. Med. 2017. 7. 21. P. 1-13. doi:10.3390/jpm7040021 www.mdpi.com/journal/jpm
30. deCODE genetics | a global leader in human genetics https://www.decode.com/
31. Feero W.G., Guttmacher A.E. Genome wide Association Studies and assessment of the risk of disease // N. Engl. J. Med. 2010. V. 363. P. 166 - 176.
32. Godard B., Schmidtke J., Cassiman J., Aymé S. Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective // Eur J Hum Genet. 2003. Suppl 2. S88-122. PMID: 14718939 DOI: 10.1038/sj.ejhg.5201114
33. Hallinan D., Friedewald M. Open consent, biobanking and data protection law: can open consent be ‘informed’ under the forthcoming data protection regulation? // Life Sciences, Society and Policy. 2015. vol. 11 Р.1-36. doi 10.1186/s40504-014-0020-9
34. https://www.decode.com/company/
35. Illig T.,Gieger C., Zhai G. et al. A genome-wide perspective of genetic variation in human metabolism // Nat. Genet. 2010. V. 42. № 2. P.137—141.
36. ISO 20387:2018 Biotechnology—Biobanking—General Requirements for Biobanking. Available online: https://www.iso.org/standard/67888.html.
37. ISO/TR 22758:2020 Biotechnology - Biobanking - Implementation guide for ISO 20387 23 р. Available online: https://www.iso.org/standard/73829.html
38. Kaye J. Moraia L. Curren L. Bell J. Mitchell C. Soini S. et al. Consent for Biobanking: The Legal Frameworks of Countries in the BioSHaRE-EU Project. Biopreserv Biobank. // Biopreservation and biobanking. 2016. Volume 14, Number 3. P. 195–200. doi: 10.1089/bio.2015.0123
39. Kinkorová J. Biobanks in the era of personalized medicine: objectives, challenges, and innovation // EPMA Journal. 2016, 7(1):4 P.1-12. doi: 10.1186/s13167-016-0053-7
40. Koch N. The biobank secret: Protection of personal rights in biomedical research: doctoral dissertation. Mainz University Library. 2014 http://doi.org/10.25358/openscience-4218
41. Laurvick C., Klerk N., Bower C., Christodoulou J., Ravine D., Ellaway C., Williamson S., Leonard H. Rett syndrome in Australia: a review of the epidemiology // J. Pediatr. 2006. V. 148(3). P. 347-352. doi: 10.1016/j.jpeds.2005.10.037
42. Litton J.E. Biobank informatics: connecting genotypes and phenotypes // Methods Mol. Biol. 2011. V. 675. Р. 343—361. doi: 10.1007/978-1-59745-423-0_21
43. Marrugat J., Lopez-Lopez J.R., Heras M. et al. The HERACLES cardiovascular Network // Rev. Esp. Cardiol. 2008. V. 61(1). P. 66—75.
44. McGinnis R., Trogstad L., Svyatova G. et. al. “Variants in the fetal genome near FLT1 are associated with risk of preeclampsia”// Nature genetics, 2017. Volume 49, Number 8. P. 1255-1260. doi: 10.1038/ng.3895
45. Mee B., Gaffney E., Glynn Sh., Donatello S., Carroll P. et. al. Development and Progress of Ireland’s Biobank Network: Ethical, Legal, and Social Implications (ELSI), Standardized Documentation, Sample and Data Release, and International Perspective Biopreservation And Biobanking Volume 11, Number 1, 2013. P. 3-11 // Mary Ann Liebert, Inc. DOI: 10.1089/bio.2012.0028
46. Mitchell R., Waldby C. National Biobanks: Clinical Labor, Risk Production, and the Creation of Biovalue // Science, Technology, & Human Values. 2010. Vol. 35, No. 3. Р. 330-355 doi: 10.1177/0162243909340267
47. Mora M., Angelini C., Bignami F., Anne-Mary Bodin A., Crimi M. et.al. The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases // European Journal of Human Genetics 2015. 23. 1116–1123
48. Morgan L., McGinnis R., Steinthorsdottir V., Svyatova G. InterPregGen: Genetic studies of pre-eclampsia in three continents // Norsk Epidemiologi, 2014. 24(1-2). P. 141–146.
49. OECD. Creation and Governance of Human Genetic Research Databases. Glossary of Statistical Terms. 2006. http://stats.oecd.org/glossary/detail.asp?ID=7220. Accessed01 Aug 2016.
50. Peakman T., Elliott P. Current Standards for the Storage of Human Samples in Biobanks // Genome Med. 2010. 2(10). 72. doi:10.1186/gm193
51. Porteri C. Management of the Ethical Aspects of a Local Mental Diseases Biobank for Research Purposes: The Italian Experience. In Ethics, Law and Governance of Biobanking: National, European and International Approaches; Mascalzoni, D., Ed.; Springer: Dordrecht, The Netherlands. 2015. Р. 219–225.
52. Riegman P.H., Dinjens W.N., Oomen M.H. et al. TuBaFrost 1: uniting local frozen tumour banks into a European network: an overview // Eur. J. Cancer. 2006. V. 42(16). P. 2678-2683. doi: 10.1016/j.ejca.2006.04.031
53. Riegman P., Morente M., Betsou F., Blasio P., Geary P., The Marble Arch International Working Group on Biobanking for Biomedical Research. Biobanking for better healthcare // Molecular Oncology. 2008. Vol.2. P.213–222.
54. Robertson L., Hall S., Jacoby P., Ellaway C., Klerk N., Leonard H. The association between behaviour and genotype in Rett Syndrome using the Australian Rett Syndrome Database // Am J Med Genet B Neuropsychiatr Genet. 2006; 141B(2): 177–183. doi: 10.1002/ajmg.b.30270
55. Svyatova G.S., Berezina G.M., Murtazaliyeva A.V. Association of polymorphisms of cardiovascular system genes with idiopathic recurrent pregnancy loss of Kazakh populations // Revista Latinoamericana de Hipertension. 2019. 14(4). 319–325
56. Steinthorsdottir V., McGinnis R., Williams N., Stefansdottir L., Thorleifsson G.,Svyatova G., Berezina G., Salimbaeva D. et.al. Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women. Nature communications. 2020. 11:5976 | https://doi.org/10.1038/s41467-020-19733-6 | www.nature.com/naturecommunications
57. Stepanov V.A., Bocharova, A.V., Saduakassova, K.Z., Vagaitseva K.V., Svyatova G.S. Replicative study of susceptibility to childhood-onset schizophrenia in Kazakhs. // Genetika. 2015. 51(2). Р. 227–235. doi: 10.1134/S102279541502014
58. Swede H., Stone C., Norwood A. National population-based biobanks for genetic research // Genetics in Medicine. 2007. Vol. 9(3). P.141–149.
59. Takako Takai-Igarashi, Kengo Kinoshita, Masao Nagasaki, Soichi Ogishima, Naoki Nakamura et.al. Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design Takai-Igarashi et al. BMC Medical Informatics and Decision Making. 2017. 17:100 P1-12 DOI 10.1186/s12911-017-0494-5
60. Tarkkala H. Reorganizing Biomedical Research: Biobanks as Conditions of Possibility for Personalized Medicine: PhD diss. Helsinki: Faculty of Social Sciences, 2019, 162 p/
61. Watson P.H., Wilson-McManus J.E., Barnes R.O. et al. Evolutionary concepts in biobanking—the BC BioLibrary // J. Trans. Med. 2009. V.7. P. 95.
62. Watts Geoff Genes on ice // BMJ. 2007. 334 (7595). P. 662–663. doi: 10.1136/bmj.39162.630914.94
63. WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. Background Paper. The Ethics of Human Genome Editing. Giulia Cavaliere, Department of Global Health and Social Medicine, King’s College London, London, U.K. 19s. https://www.who.int/ethics/topics/human-genome-editing/WHO-Commissioned-Ethics-paper-March19.pdf
64. Yuzbasioglu A., Kesikli B., Ozguc M. Biobanks as basis if individualized medicine: Challenges toward harmonization. In Precision Medicine: Tools and Quantitative Approaches; Deigner, H.-P., Kohl, M.E., Fedor, J., Eds.; Academic Press: London, UK, 2018; Volume 4, pp. 57–77.
65. Zika E., Paci D., Schulte in den Bäumen T., Braun A., Rijkers-Defrasne S., Deschênes M., Fortier I., Laage-Hellman J., Scerri C.A., Ibarreta D. Institute for Prospective Technological Studies. In Biobanks in Europe: Prospects for Harmonisation and Networking; Publications O_ce: Luxembourg, 2010.
References:
1. Bragina E.Ju., Bujkin S.V., Puzyrev V.P. Biologicheskie banki: problemy i perspektivy ih ispol'zovanija v issledovanijah geneticheskih aspektov kompleksnyh zabolevanij cheloveka [Biological banks: problems and prospects of their use in the study of genetic aspects of complex human diseases]. Meditsinskaya genetika [Medical genetics]. 2009. №3. pp.20-27. [In Russian]
2. Bryzgalina E.V., Alasanija K.Ju., Sadovnichij V.A., Mironov V.V., Gavrilenko S.M., Varhotov T.A., Shkomova E.M., Nabiulina E.A. Social'no-gumanitarnaya ekspertiza funktsionirovaniya natsional'nykh depozitariev biomaterialov [Socio-humanitarian examination of the functioning of national depositories of biomaterials]. Voprosy filosofii [Problems of Philosophy]. 2016. №2. pp. 18–21 http://vphil.ru/index.php?option=com_content&task=view&id=1346&Itemid=5 [In Russian]
3. Bujkin S.V., Bragina E.Ju., Koneva L.A., Puzyrev V.P. Bazy dannykh kollektsii biologicheskogo materiala: organizatsiya soprovoditel'noi informatsii [Databases of collections of biological material: organization of accompanying information]. Byulleten' sibirskoi meditsiny. [Bulletin of Siberian Medicine]. 2012. No.1(26). pp.111-121. [In Russian]
4. Varhotov T.A. i dr. Zadachi sotsial'no-gumanitarnogo soprovozhdeniya sozdaniya natsional'nogo banka-depozitariya biomaterialov [Tasks of social and humanitarian support for the creation of a national depository bank for biomaterials]. Voprosy filosofii [Problems of Philosophy]. 2016. No.3. P.124–138.] [In Russian]
5. Eropkin M.Ju. Biobanki i ikh rol' v sistemakh biobezopasnosti, zdravookhraneniya, biotekhnologii, ekologii i «ekonomike znanii» FGBU «NII grippa» Minzdrava Rossii [Biobanks and their role in biosafety, health care, biotechnology, ecology and the "knowledge economy" FSBI "Research Institute of Influenza" of the Ministry of Health of Russia], 2015. P 1-25. www.influenza.spb.ru [In Russian]
6. Ignasimutu S. Osnovy bioinformatiki. [Fundamentals of Bioinformatics]. NIC «Regulyarnaya i khaoticheskaya dinamika». Institut komp'uuternykh issledovanii [Research Center "Regular and Chaotic Dynamics". Institute for Computer Research], Izhevsk:2007. 320 p. [In Russian]
7. Konshina O.S., Eropkin M.Ju., Nikonorov I.Ju., Pozdnjakova M.G. Rol' biobankov v izuchenii populyatsionnogo immuniteta [The role of biobanks in the study of population immunity]. Zhurnal infektologii [Journal of Infectology]. 2018.vol. 10, No. 2 pp. 39-47. doi: 10.22625 / 2072-6732 [In Russian]
8. Maleina M.N. Pravovoi status biobanka (banka biologicheskikh materialov cheloveka). [The legal status of the biobank (bank of human biological materials). Pravo. Zhurnal Vysshei shkoly ekonomiki [Law. Journal of the Higher School of Economics]. 2020. No. 1. P. 98–117. doi: 10.17323 / 2072-8166.2020.1.98.117 [In Russian]
9. Mirzahmetova D.D. Svjatova G.S., Berezina G.M., Murtazalieva A.V. Kliniko-diagnosticheskaya znachimost' genov predraspolozhennosti k preeklampsii v kazakhskoi populyatsii [Clinical and diagnostic significance of genes for predisposition to preeclampsia in the Kazakh population]. Akusherstvo i ginekologiya [Obstetrics and gynecology], 2020. - No. 3 P.58-63. https://dx.doi.org/10.18565/aig.2020.3.58-63] [In Russian]
10. Mihajlova A.A., Nasyhova Ju.A., Murav'ev A.I., Efimenko A.Ju., Glotov A.S. Na puti k sozdaniyu obshhego glossariya biobankov Rossiiskoi Federatsii [Towards the creation of a general glossary of biobanks of the Russian Federation]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention]. 2020.19 (6) pp.134-148 doi: 10.15829 / 1728-8800-2020-2710 [In Russian]
11. Mohov A.A. Biobanking — novoe napravlenie ekonomicheskoi deyatel'nosti [Biobanking is a new direction of economic activity]. Vestnik MGJuA [Bulletin of the Moscow State Law Academy]. 2018. No. 3. P. 33–40. [In Russian]
12. Ob utverzhdenii pravil sozdaniya i deyatel'nosti biobankov. Prikaz i.o. Ministra zdravookhraneniya Respubliki Kazakhstan ot 24 dekabrya 2020 goda № ҚR DSM-328/2020 [On the approval of the rules for the creation and operation of biobanks. Order of the acting Minister of Health of the Republic of Kazakhstan dated December 24, 2020 No. №Р DSM-328/2020] [In Russian]
13. Przhilenskij V.M., Vergun A.A. Pravovoe regulirovanie deyatel'nosti genomnykh bankov v kontekste sotsial'nogo, kul'turnogo i normativnogo mnogoobraziya [Legal regulation of genomic banks in the context of social, cultural and regulatory diversity]. Aktual'nye problemy rossijskogo prava [Actual problems of Russian law]. 2019. No. 3. P. 30–37. [In Russian]
14. Reznik O.N., Kuz'min D.O., Skvorcov A.E., Reznik A.O. Biobanki – neotsenimyi resurs transplantatsii. Istoriya, sovremennoe sostoyanie, perspektivy [Biobanks are an invaluable resource for transplantation. History, current state, prospects]. Vestnik transplantologii i iskusstvennyh organov [Bulletin of transplantology and artificial organs]. 2016.Vol. XVIII No. 4 C.123-132. doi: 10.15825 / 1995-1191 [In Russian]
15. Rumjancev P.O., Mudunov A.M. Biobanking v onkologii i radiologii [Biobanking in Oncology and Radiology]. Endokrinnaya khirurgiya [Endocrine Surgery]. 2017.Vol. 11.No.4. pp 170-177. doi: 10.14341 / serg9555 [In Russian]
16. Svjatova G.S., Berezina G.M., Mamedalieva N.M., Aimbetova A.R., Murtazalieva A.V. Molekulyarno-geneticheskaya diagnostika i algoritm vedeniya beremennykh s idiopaticheskoi formoi privychnogo nevynashivaniya [Molecular genetic diagnostics and an algorithm for the management of pregnant women with idiopathic recurrent miscarriage]. Metodicheskie rekomendatsii [Methodical recommendations], 2019. - 28p., Approved on December 20, 2019 No. 206 by the Republican State Enterprise at the RCCRH, ISBN 978-601-305-371-4 [In Russian]
17. Svjatova G.S., Berezina G.M., Mierbekov E.M., Murtazalieva A.V. Chastoty allelei i genotipov, associirovannykh s effektivnost'yu antikoaguljantnoi terapii, v kazakhskoi populyatsii [Frequencies of alleles and genotypes associated with the effectiveness of anticoagulant therapy in the Kazakh population]. Meditsinskaya genetika [Medical genetics], 2018. No.9. P.37-44. https://doi.org/10.25557/2073-7998.2018.09.37-44] [In Russian]
18. Svjatova G.S., Berezina G.M., Murtazalieva A.V. Assotsiatsiya polimorfizma gena khromosomnoi segregatsii SYCP3 s idiopaticheskoi formoi privychnogo nevynashivaniya beremennosti v kazakhskoi populyatsii [Association of SYCP3 chromosomal segregation gene polymorphism with idiopathic recurrent miscarriage in the Kazakh population]. Akusherstvo i ginekologiya [Obstetrics and gynecology], 2019. No.12 P.105-110. https://dx.doi.org/10.18565/aig.2019.12.105-110 [In Russian]
19. Svjatova G.S., Berezina G.M., Salimbaeva D.N., Kirikbaeva M.S., Murtazalieva A.V.,Saduakasova K.Z. Geneticheskie aspekty idiopaticheskoj formy privychnogo nevynashivanija beremennosti. (Obzor literatury) [Genetic aspects of the idiopathic form of recurrent miscarriage. (Literature review)]. Nauka i zdravookhranenie [Science & Healthcare], 2019. No.4(V.21). pp.37-49. ISSN2410 – 4280 [In Russian]
20. Smirnova Ju. «Bankovskoe delo» kak put' k personifitsirovannoi meditsine, [Smirnova Yu. «Banking» as a path to personalized medicine]. Nauka i zhizn' [Science and Life], 2013 №1 https://www.nkj.ru/archive/articles/21579/ [In Russian]
21. Tsentr kollektivnogo pol'zovaniya «Biobank», FGBU «NMIC im. V.A.Almazova» Minzdrava Rossii. [Center for collective use "Biobank", FSBI "NMITs im. VA Almazov "of the Ministry of Health of Russia]. http://www.almazovcentre.ru/?page_id=69701 [In Russian]
22. Allocca C.M., Bledsoe M.J., Furuta K., Ramirez N.C. ISO/TC276/WG2 Biobanks and Bioresources: Draft International Standard Is Now Available for Comment. Biopreserv. Biobank. 2017. Vol. 15(4). P.399–401. doi: 10.1089/bio.2017.29025.cma
23. Asslaber M., Zatloukal K. Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic. 2007. Vol. 6(3). P.193-201. doi: 10.1093/bfgp/elm023. Epub 2007 Oct 4.
24. Barbour V. UK Biobank: a project in search of a protocol? Lancet (London, England). 2003. 361(9370). P.1734-1738. DOI:10.1016/s0140-6736(03)13377-6
25. Berezina G., Svyatova G., Aimbetova A. “Genes of predisposition to misseb abortion in kazakh population”. Abstract book / International scientific conference «Personalized medicine & Global Health». 2017 г. P 46.
26. Best Practices for Repositories Collection, Storage, Retrieval, and Distribution of Biological Materials for Research International Society for Biological and Environmental Repositories. Biopreserv. Biobank. 2012. 10. 79–161.
27. Betsou F., Bulla A., Cho S.Y., Clements J., Chuaqui, R. et.al. Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group. Biopreserv. Biobank. 2016. 14(5). P.398–409. doi: 10.1089/bio.2016.0018
28. Bingham S., Riboli E. Diet and cancer — the European prospective investigation into cancer and nutrition. Nat. Rev. Cancer. 2004. V. 4(3). P. 206-215. doi: 10.1038/nrc1298
29. Bourgeois F., Avillach P., Kong S., Heinz M., Tran T. Development of the Precision Link Biobank at Boston Children’s Hospital: Challenges and Opportunities. J. Pers. Med. 2017. 7. 21. P. 1-13. doi:10.3390/jpm7040021 www.mdpi.com/journal/jpm
30. deCODE genetics | a global leader in human genetics https://www.decode.com/
31. Feero W.G., Guttmacher A.E. Genome wide Association Studies and assessment of the risk of disease. N. Engl. J. Med. 2010. V. 363. P. 166 - 176.
32. Godard B., Schmidtke J., Cassiman J., Aymé S. Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective. Eur J Hum Genet. 2003. Suppl 2. S88-122. PMID: 14718939 DOI: 10.1038/sj.ejhg.5201114
33. Hallinan D., Friedewald M. Open consent, biobanking and data protection law: can open consent be ‘informed’ under the forthcoming data protection regulation? Life Sciences, Society and Policy. 2015. vol. 11 Р.1-36. doi 10.1186/s40504-014-0020-9
34. https://www.decode.com/company/
35. Illig T.,Gieger C., Zhai G. et al. A genome-wide perspective of genetic variation in human metabolism. Nat. Genet. 2010. V. 42. № 2. P.137—141.
36. ISO 20387:2018 Biotechnology—Biobanking—General Requirements for Biobanking. Available online: https://www.iso.org/standard/67888.html.
37. ISO/TR 22758:2020 Biotechnology - Biobanking - Implementation guide for ISO 20387 23 р. Available online: https://www.iso.org/standard/73829.html
38. Kaye J. Moraia L. Curren L. Bell J. Mitchell C. Soini S. et al. Consent for Biobanking: The Legal Frameworks of Countries in the BioSHaRE-EU Project. Biopreserv Biobank. Biopreservation and biobanking. 2016. Volume 14, Number 3. P. 195–200. doi: 10.1089/bio.2015.0123
39. Kinkorová J. Biobanks in the era of personalized medicine: objectives, challenges, and innovation. EPMA Journal. 2016, 7(1):4 P.1-12. doi: 10.1186/s13167-016-0053-7
40. Koch N. The biobank secret: Protection of personal rights in biomedical research: doctoral dissertation. Mainz University Library. 2014 http://doi.org/10.25358/openscience-4218
41. Laurvick C., Klerk N., Bower C., Christodoulou J., Ravine D., Ellaway C., Williamson S., Leonard H. Rett syndrome in Australia: a review of the epidemiology. J. Pediatr. 2006. V. 148(3). P. 347-352. doi: 10.1016/j.jpeds.2005.10.037
42. Litton J.E. Biobank informatics: connecting genotypes and phenotypes. Methods Mol. Biol. 2011. V. 675. Р. 343—361. doi: 10.1007/978-1-59745-423-0_21
43. Marrugat J., Lopez-Lopez J.R., Heras M. et al. The HERACLES cardiovascular Network. Rev. Esp. Cardiol. 2008. V. 61(1). P. 66—75.
44. McGinnis R., Trogstad L., Svyatova G. et. al. “Variants in the fetal genome near FLT1 are associated with risk of preeclampsia”. Nature genetics, 2017. Volume 49, Number 8. P. 1255-1260. doi: 10.1038/ng.3895
45. Mee B., Gaffney E., Glynn Sh., Donatello S., Carroll P. et. al. Development and Progress of Ireland’s Biobank Network: Ethical, Legal, and Social Implications (ELSI), Standardized Documentation, Sample and Data Release, and International Perspective Biopreservation And Biobanking Volume 11, Number 1, 2013. P. 3-11. Mary Ann Liebert, Inc. DOI: 10.1089/bio.2012.0028
46. Mitchell R., Waldby C. National Biobanks: Clinical Labor, Risk Production, and the Creation of Biovalue. Science, Technology, & Human Values. 2010. Vol. 35, No. 3. Р. 330-355 doi: 10.1177/0162243909340267
47. Mora M., Angelini C., Bignami F., Anne-Mary Bodin A., Crimi M. et.al. The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases. European Journal of Human Genetics. 2015. 23. 1116–1123
48. Morgan L., McGinnis R., Steinthorsdottir V., Svyatova G. InterPregGen: Genetic studies of pre-eclampsia in three continents. Norsk Epidemiologi, 2014. 24(1-2). P. 141–146.
49. OECD. Creation and Governance of Human Genetic Research Databases. Glossary of Statistical Terms. 2006. http://stats.oecd.org/glossary/detail.asp?ID=7220.(Accessed 01 Aug 2016).
50. Peakman T., Elliott P. Current Standards for the Storage of Human Samples in Biobanks. Genome Med. 2010. 2(10). 72. doi:10.1186/gm193
51. Porteri C. Management of the Ethical Aspects of a Local Mental Diseases Biobank for Research Purposes: The Italian Experience. In Ethics, Law and Governance of Biobanking: National, European and International Approaches; Mascalzoni, D., Ed.; Springer: Dordrecht, The Netherlands. 2015. Р. 219–225.
52. Riegman P.H., Dinjens W.N., Oomen M.H. et al. TuBaFrost 1: uniting local frozen tumour banks into a European network: an overview. Eur. J. Cancer. 2006. V. 42(16). P. 2678-2683. doi: 10.1016/j.ejca.2006.04.031
53. Riegman P., Morente M., Betsou F., Blasio P., Geary P., The Marble Arch International Working Group on Biobanking for Biomedical Research. Biobanking for better healthcare. Molecular Oncology. 2008. Vol.2. P.213–222.
54. Robertson L., Hall S., Jacoby P., Ellaway C., Klerk N., Leonard H. The association between behaviour and genotype in Rett Syndrome using the Australian Rett Syndrome Database. Am J Med Genet B Neuropsychiatr Genet. 2006; 141B(2): 177–183. doi: 10.1002/ajmg.b.30270
55. Svyatova G.S., Berezina G.M., Murtazaliyeva A.V. Association of polymorphisms of cardiovascular system genes with idiopathic recurrent pregnancy loss of Kazakh populations. Revista Latinoamericana de Hipertension. 2019. 14(4). 319–325
56. Steinthorsdottir V., McGinnis R., Williams N., Stefansdottir L., Thorleifsson G.,Svyatova G., Berezina G., Salimbaeva D. et.al. Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women. Nature communications. 2020. 11:5976 https://doi.org/10.1038/s41467-020-19733-6 www.nature.com/naturecommunications
57. Stepanov V.A., Bocharova, A.V., Saduakassova, K.Z., Vagaitseva K.V., Svyatova G.S. Replicative study of susceptibility to childhood-onset schizophrenia in Kazakhs. Genetika. 2015. 51(2). Р. 227–235. doi: 10.1134/S102279541502014
58. Swede H., Stone C., Norwood A. National population-based biobanks for genetic research // Genetics in Medicine. 2007. Vol. 9(3). P.141–149.
59. Takako Takai-Igarashi, Kengo Kinoshita, Masao Nagasaki, Soichi Ogishima, Naoki Nakamura et.al. Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design Takai-Igarashi et al. BMC Medical Informatics and Decision Making. 2017. 17:100 P1-12 DOI 10.1186/s12911-017-0494-5
60. Tarkkala H. Reorganizing Biomedical Research: Biobanks as Conditions of Possibility for Personalized Medicine: PhD diss. Helsinki: Faculty of Social Sciences, 2019, 162 p/
61. Watson P.H., Wilson-McManus J.E., Barnes R.O. et al. Evolutionary concepts in biobanking—the BC BioLibrary. J. Trans. Med. 2009. V.7. P. 95.
62.Watts Geoff Genes on ice. BMJ. 2007. 334 (7595). P. 662–663. doi: 10.1136/bmj.39162.630914.94
63. WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. Background Paper. The Ethics of Human Genome Editing. Giulia Cavaliere, Department of Global Health and Social Medicine, King’s College London, London, U.K. 19s. https://www.who.int/ethics/topics/human-genome-editing/WHO-Commissioned-Ethics-paper-March19.pdf
64. Yuzbasioglu A., Kesikli B., Ozguc M. Biobanks as basis if individualized medicine: Challenges toward harmonization. In Precision Medicine: Tools and Quantitative Approaches; Deigner, H.-P., Kohl, M.E., Fedor, J., Eds.; Academic Press: London, UK, 2018; Volume 4, pp. 57–77.
65. Zika E., Paci D., Schulte in den Bäumen T., Braun A., Rijkers-Defrasne S., Deschênes M., Fortier I., Laage-Hellman J., Scerri C.A., Ibarreta D. Institute for Prospective Technological Studies. In Biobanks in Europe: Prospects for Harmonisation and Networking; Publications O_ce: Luxembourg, 2010.
Количество просмотров: 457
Категория статей:
Медицинское образование
Библиографическая ссылка
Березина Г.М., Мирзахметова Д.Д., Святова Г.C., Терликбаева А.Т., Муртазалиева А.В. Организация биобанка ДНК и его роль в научных исследованиях // Наука и Здравоохранение. 2021. 4(Т.23). С. 208-217. doi 10.34689/SH.2021.23.4.023Похожие публикации:
АНАЛИЗ ИТОГОВОЙ ОЦЕНКИ ДИСЦИПЛИН ОБУЧАЮЩИХСЯ ШКОЛЫ ОБЩЕСТВЕННОГО ЗДРАВООХРАНЕНИЯ, СТОМАТОЛОГИИ, ФАРМАЦИИ И СЕСТРИНСКОГО ДЕЛА В 2022-2023 УЧЕБНОМ ГОДУ
SYSTEMIZING INTERNATIONAL ACADEMIC EXCHANGES AND THE ENROLLMENT OF STUDY ABROAD STUDENTS AND SUSTAINING THAT APPROACH: SEEKING TO ESTABLISH FURTHER COOPERATIVE FRAMEWORKS IN SEMEY AND JAPAN (KOCHI AND HIROSHIMA)
COMPARATIVE ANALYSIS OF KNOWLEDGE, ATTITUDES, AND BEHAVIOR IN EVIDENCE-BASED NURSING PRACTICE AMONG ACADEMIC AND APPLIED BACHELOR'S DEGREE STUDENTS
АНАЛИЗ ИТОГОВОЙ ОЦЕНКИ ДИСЦИПЛИН ОБУЧАЮЩИХСЯ ШКОЛЫ МЕДИЦИНЫ В 2022-2023 УЧЕБНОМ ГОДУ
PSYCHOLOGICAL SUPPORT FOR PARENTS RAISING CHILDREN WITH AUTISM SPECTRUM DISORDERS